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Background: Temporomandibular pain disorder (TMD) is a common pain condition in the face. People with TMD
report multiple pain comorbidities. The presence of fibromyalgia and migraine in people with TMD is associated
with an increase in TMD pain intensity and duration. However, data on the relationship between increasing number
of pain comorbidities and TMD pain are rare. The aims of this study were: firstly to evaluate the extent to which
increasing number of comorbidities is associated with increasing TMD pain intensity and duration; and secondly to
evaluate the extent to which the presence of specific comorbidities is associated with increasing TMD pain intensity
and duration.
Methods: The sample included 180 people seeking TMD treatment at Boston and Montreal clinics. TMD was
diagnosed using the Research Diagnostic Criteria for TMD. A Numerical Pain Rating Scale assessed TMD pain
intensity and participants provided their TMD pain duration in a study questionnaire. The comorbidities of migraine,
chronic fatigue syndrome, irritable bowel syndrome, interstitial cystitis and restless leg syndrome were diagnosed
by 5 validated diagnostic questionnaires. The associations were analyzed by linear regression, controlling for
confounders.
Results: There was a positive association between the number of comorbidities present and TMD pain intensity
(p < 0.01) and between the number of comorbidities present and TMD pain duration (p < 0.01). Also, the presence of
migraine was positively associated with TMD pain intensity (p < 0.01) and the presence of chronic fatigue syndrome
was positively associated with TMD pain intensity (p < 0.05) and with TMD pain duration (p < 0.01). When TMD patients
were separated into groups, these associations did not change for the myofascial pain group, whereas in the
non-myofascial pain group, the relationship between number of comorbidities and TMD pain duration was the
only one still present.
Conclusion: This study shows that the number of comorbidities is positively associated with TMD pain duration
and intensity. The presence of specific conditions, such as migraine and chronic fatigue syndrome, is associated
with an increase in TMD intensity and duration.
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Temporomandibular pain disorder (TMD) is a common
pain condition in the face, with a prevalence of 5–33 %
[1, 2]. TMD includes pain in the temporomandibular
joint, disc, and surrounding muscles [3]. People with
TMD report multiple pain comorbidities [4, 5]. The
presence of widespread pain is associated with onset and
increase of TMD pain intensity, duration, and disability
[6–10]. However, data on the relationship between TMD
pain and multiple pain comorbidities that are not wide-
spread is rare [11]. Widespread pain may not be a good
indicator of multiple pain comorbidities since it tends
to be more severe, longer lasting, and accompanied by
decreased functionality and poorer general health [12].
Therefore, additional research is necessary to under-
stand the relationship between multiple comorbidities
and TMD pain intensity and duration.
Recent research in other pain conditions has revealed
that some comorbidities interact with pain in more harmful
ways. For example, having heart disease, depression, or anx-
iety increased the odds of having pain 5 years after total
knee replacement by over 1.5 times, whereas having dia-
betes or renal disease did not [13]. In people with TMD,
the presence of migraine and fibromyalgia is associated
with an increased TMD pain and disability [6, 7, 14–17].
However, there are few data of whether other comorbidities
are associated with TMD pain intensity or duration.
In addition, people with myofascial TMD (m-TMD)
have been observed to have more severe and longer-
lasting pain, and experience more dysfunction and disabil-
ity when compared to people with non-myofascial TMD
(j-TMD) [18]. However, it is unknown whether people
with m-TMD exhibit differences in the relationships be-
tween number and specific comorbidities and TMD pain.
This study had three aims: Firstly, to describe the rela-
tionship between the number of comorbidities and TMD
pain duration and intensity. We hypothesized that the
number of comorbidities would be positively associated
with levels of TMD pain intensity and duration. Secondly,
we aimed to observe the association of five specific co-
morbidities and TMD pain duration and intensity. The
presence of migraine was hypothesized to be associated
with an increased TMD pain intensity and duration be-
cause of past studies indicating this relationship [15, 16].
No hypothesis was made for the other conditions since no
prior data are available. Finally, we aimed to dichotomize
participants into two TMD groups: m-TMD and j-TMD
to test if the above associations remain the same for both
TMD groups. We hypothesized that the same relationship
would be observed in both groups.
Methods
Ethical approval to perform the study was granted from
the Institutional Review Boards of McGill University andthe Massachusetts General Hospital before the start of
data collection. A written informed consent form was
obtained from all participants prior to joining the study.
This cross-sectional multi-center study included patients
with TMD treated in three clinics: The Division of Den-
tistry at the Montreal General Hospital, the Department
of Oral and Maxillofacial Surgery and Orofacial Pain
Clinic at the Massachusetts General Hospital. At the
Massachusetts General Hospital patients that fulfilled
the inclusion criteria were approached during routine
clinic visits and were invited to participate. At the Mon-
treal General Hospital, inactive patients of a TMD clinic
that had since been closed that were deemed eligible by
a chart-review were invited to join the study by a letter
mailed to their last known address. Patients with chronic
TMD, lasting for more than 6 months, were included in
the study [19]. Excluded were patients with acute pain,
other types of comorbid orofacial pain condition (neuro-
pathic, burning mouth syndrome, atypical) and a history
of TMJ surgery. Eligible participants who agreed to par-
ticipate were diagnosed with TMD by a clinical exam
using the Research Diagnostic Criteria (RDC/TMD) [20]
by two experienced dentists. The Kappa score between
the two clinicians was considered good (0.88, 95 % CI
0.65-1.00) [21]. The sample size was calculated for a lin-
ear regression model with an effect size between the out-
come variables and predictor variable that is deemed as
medium (F2 = 0.15), and a maximum number of predic-
tors of 6 (the primary predictor variable, two known
confounders like age and sex and three other potential
confounders) [22]. A sample of 97 was deemed neces-
sary for a significance level of 0.05 and power at 80 %.
Data collection
The current study assessed the following variables: TMD
pain intensity and duration as outcome variables, and
presence and number of specific comorbidities as expos-
ure variables. The comorbidities were migraine, chronic
fatigue syndrome (CFS), irritable bowel syndrome (IBS),
interstitial cystitis (IC), and restless leg syndrome (RLS),
all more prevalent in people with TMD than the general
population [4]. To assess the presence of specific comor-
bidities, each participant completed 5 validated diagnos-
tic questionnaires: the ID Migraine [23], the Schedule of
Fatigue and Anergia [24], the ROME III [25], the Pain,
Urgency and Frequency Symptom Scale [26], and the
Cambridge-Hopkins Restless Leg Syndrome Questionnaire-
short form [27]. These questionnaires all have very good
sensitivity (range 81 % to 93 %), specificity (range 70 % to
95 %), and positive predictive value (range 70 to 94 %). Par-
ticipants also completed a study questionnaire that assessed
sociodemographic information and history of depression
and anxiety. To assess the outcome variables, the duration
of TMD pain was assessed in the study questionnaire by
Table 1 Socio-demographic characteristics of the study
participants
Variables No comorbidity With comorbidity P value
(n = 68) (n = 112)
Age, mean years (SD) 44.77 (15.6) 41.59 (15.3) 0.18
Female gender, n (%) 52 (76.5) 97 (86.6) 0.08
Marital Status, n (%) 0.08
Single 17 (25.0) 46 (41.1)
Married 43(63.2) 49 (43.8)
Divorced 6 (8.8) 14 (12.5)
Widowed 2 (2.9) 3 (2.7)
M-TMD n (%) 37 (54.4) 84 (75.9) <0.01
Pain intensity, mean (SD) 4.57 (2.7) 5.43 (2.3) 0.03
Pain Duration, mean
years (SD)
4.50 (6.9) 7.44 (8.5) 0.02
Positive history of depression
and/or anxiety, n (%)
30 (44.1) 70(62.5) 0.02
Work Status, n (%) 0.02
Unemployed 11 (16.7) 33 (29.5)
On disability 1 (1.5) 11 (9.8)
Part-time 17 (25.0) 15 (13.4)
Full-time 39 (57.3) 53 (47.3)
Education Status, n (%) 0.85
Did not finish high school 4 (5.8) 5 (4.5)
Finished high school 14 (20.6) 22 (19.6)







Type of comorbidity, n (%)
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current TMD pain intensity was assessed by the Numerical
Pain Rating Scale [28] from 0 to 10.
Subjects were stratified into two TMD subgroups based
on the presence of myofascial pain: m-TMD were partici-
pants who had myofascial pain, whether alone or in com-
bination with other forms of TMD disorder; j-TMD were
participants who were free of myofascial pain, but had
other forms of TMD disorder. For the current study, m-
TMD corresponded to the RDC/TMD group I (myofascial
pain) alone, or in combination with group II (disc dis-
placement) and/or group III (other joint conditions) and
j-TMD corresponded to the RDC/TMD group II (disc dis-
placement) and/or group III (other joint conditions).
Data analysis
In order to reveal possible confounders, socio-demographic
differences were compared between participants with and
without comorbidities. Means and frequencies were used
for continuous and categorical variables respectively. Differ-
ences in socio-demographic variables were tested using T-
test for continuous variables and Chi-squared test for
categorical variables. The selection of potential con-
founder included both a priori and empirical consider-
ations. For empirical evidence, we included the covariates
with a p-value equal to or less than 0.25 as confounders
[29]. A test for co-linearity between the exposure variables
was also completed using variance inflation factor (VIF)
larger than 10 as evidence of co-linearity between two ex-
posure variables.
To analyze the relationships between the number of
comorbidities present and the two outcome variables
(TMD pain intensity and duration) and between specific
comorbidities and the two outcome variables (TMD pain
intensity and duration), multivariate linear regression
analyses were done taking into account the confounding
variables. For each outcome variable, three models of re-
gression were performed: 1) Crude Model with no con-
founding variables, 2) Complete Model including all
potential confounders and 3) Simple Model including
only confounders that met the change-of-estimate criter-
ion set at 20 % [30].
Finally, we dichotomized the participants based on
presence of myofascial pain (m-TMD and j-TMD) and
re-ran the regression models to reveal the relationship of
comorbidities and outcome variables based on TMD
subgroups. Linear regression coefficient, the 95 % confi-
dence intervals, p value and R2 values were estimated in
all analyses. Statistical analyses were performed using
Stata (version 10).
Results
A total of 224 participants agreed to partake in the study,
of which 209 participants were from the MassachusettsGeneral Hospital and 15 were from the Montreal General
Hospital. Forty-four subjects were excluded from the
study: 31 for not fulfilling the inclusion criteria and 13 for
not completing all questionnaires. A final sample of 180
people completed the study. The final sample of 180 par-
ticipants completed the study, which 68 (37.8 %) had no
comorbidities, 54 (30.0 %) had one comorbidity and 58
(32.2 %) had at least two comorbidities (Table 1). Partici-
pants with and without comorbidities differed in some
of the socio-demographic characteristics: subjects with
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of TMD pain and were more likely to have m-TMD, have
a positive history of depression and/or anxiety and differ
in work status.
The covariate analysis for outcome variable, TMD pain
duration, revealed that the confounders were sex, TMD
group, marital status, work status and psychological his-
tory. Age was not found to be significant as a con-
founder but was included in the regression model due to
the overwhelming evidence from previous research of
the association with the chosen variables [31]. The co-
variate analysis for outcome variable, TMD pain inten-
sity, revealed that the confounders were TMD group,
work status and psychological history. Sex and age were
included in the regression model from previous research
of the association with our variables [31]. The test for
co-linearity revealed that the exposure variable - the
number of comorbidities, was highly correlated with the
five tested comorbidities (VIF = 94). This result is not
surprising, since the presence or absence of the five co-
morbidities in a participant defined his/her number of
comorbidities (0 to 5).
Our analyses demonstrated a positive association be-
tween the number of comorbidities and TMD pain in-
tensity in a dose–response fashion (Fig. 1). A positive
association was also found between the number of co-
morbidities and TMD pain duration (Fig. 2).
Tables 2 and 3 show the result of the linear regression
analysis comparing TMD pain duration and intensity as
outcome variables. After controlling for confoundingFig. 1 The association between TMD pain intensity (0–10) and the numbevariables there was a significant association between the
number of comorbidities and TMD pain duration in all
three regression models. As well, there was an associ-
ation between the number of comorbidities and TMD
pain intensity in all three models. The regression models
of specific comorbidities indicated that the presence of
CFS had the strongest association with both TMD pain
duration and intensity. The presence of migraine was as-
sociated with a one-point increase in TMD pain inten-
sity. The other comorbidities were not associated with
either TMD pain intensity or duration.
Finally, we dichotomized the participants based on the
presence of m-TMD and re-ran the regression models to
reveal the relationship of comorbidities and our outcome
variables based on TMD subgroups. Tables 4 and 5 show
that the associations in the combined TMD group held
true for the m-TMD subgroup. However, Tables 6 and 7
indicate that in the j-TMD group, the only association
observed was between the number of comorbidities and
TMD pain duration. All other associations observed in
the combined TMD group did not meet statistical sig-
nificance in the j-TMD subgroup.
Discussion
In this cross-sectional study, more than 62 % of partici-
pants suffered from at least one comorbid condition,
with migraine, IBS and RLS being the most prevalent.
This percentage is similar to previous results, showing
that 70 % of people with painful TMD had at least one
comorbidity [32]. Clearly, people with chronic TMDr of comorbidities in all TMD participants (n = 180)
Fig. 2 The association between TMD pain duration (years) and the number of comorbidities in all TMD participants (n = 180)
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pains. Compared to people without comorbidities, partici-
pants with comorbidities were more likely to be females
with m-TMD, with a history of depression and/or anxiety
and experiencing higher TMD pain intensity. These differ-
ences confirm earlier research, suggesting that the pres-
ence of comorbidities in patients with TMD may signify a
more complex disorder [5, 7, 33–36].Table 2 Results of multiple linear regression models comparing bet
TMD group (n = 180)
Outcome variables Exposure variables Crude M
Coefficie
p value,




Chronic Fatigue Syndrome 6.58 (3.3
p < 0.01,
Irritable Bowel Syndrome 3.03 (0.4
p = 0.02,
Interstitial Cystitis 4.04 (0.4
p = 0.03,
Restless Leg Syndrome 1.68 (−1
p = 0.30,Our study revealed a positive relationship between the
number of comorbid conditions present and TMD pain
duration and intensity. To our knowledge, our study is
the first to look at this relationship using linear regression
analyses, allowing control for other comorbid conditions
and confounders. One previous study found a correlation
between increasing number of pain symptoms and greater
TMD pain severity [37], while other studies have foundween comorbidities and TMD pain duration in the combined
odel Complete model Simple model
nt (95 % CI) Coefficient (95 % CI) Coefficient (95 % CI)
r2 value p value, r2 value p value, r2 value
8 – 2.68) 1.64 (0.62 – 2.65) 1.56 (0.59 – 2.53)
r2 = 0.06 p < 0.01, r2 = 0.13 p < 0.01, r2 = 0.13
.83 – 3.95) 0.28 (−2.31 – 2.87) 0.01 (−2.47 – 2.49)
r2 = 0.01 p = 0.83, r2 = 0.17 p = 0.99, r2 = 0.16
2 – 9.84) 6.03 (2.52 – 9.54) 5.84 (2.38 – 9.30)
r2 = 0.08 p < 0.01, r2 = 0.17 p < 0.01, r2 = 0.16
2 – 5.65) 2.24 (−0.41 – 4.90) 2.15 (−0.47 – 4.77)
r2 = 0.03 p = 0.10, r2 = 0.17 p = 0.11, r2 = 0.16
4 – 7.64) 0.71 (−3.17 – 4.59) 0.78 (−3.03 – 4.59)
r2 = 0.03 p = 0.72, r2 = 0.17 p = 0.69, r2 = 0.16
.52 – 4.87) −0.16 (−3.39 – 3.07) −0.15 (−3.35 – 3.04)
r2 = 0.01 p = 0.92, r2 = 0.17 p = 0.92, r2 = 0.16
Table 3 Results of multiple linear regression models comparing between comorbidities and TMD pain intensity in the combined
TMD group (n = 180)
Outcome variables Exposure variables Crude Model Complete model Simple model
Coefficient (95 % CI) Coefficient (95 % CI) Coefficient (95 % CI)
p value, r2 value p value, r2 value p value, r2 value
TMD intensity (0–10) Number of comorbidities 0.57 (0.27 – 3.95) 0.46 (0.14 – 0.78) 0.46 (0.15 – 0.78)
p < 0.01, r2 = 0.07 p < 0.01, r2 = 0.10 p < 0.01, r2 = 0.10
Migraine 1.43 (0.71 – 2.15) 1.02 (0.20 – 1.84) 1.08 (0.30 – 1.87)
p < 0.01, r2 = 0.08 p < 0.05, r2 = 0.15 p < 0.01, r2 = 0.14
Chronic Fatigue Syndrome 1.85 (0.83 – 2.88) 1.07 (−0.03 – 2.19) 1.12 (0.03 – 2.22)
p < 0.01, r2 = 0.07 p = 0.06, r2 = 0.15 p < 0.05, r2 = 0.14
Irritable Bowel Syndrome 0.66 (−0.167 –1.48) 0.10 (−0.73 – 0.94) 0.10 (−0.73 – 0.93)
p = 0.12, r2 = 0.01 p = 0.81, r2 = 0.15 p = 0.81, r2 = 0.14
Interstitial Cystitis 1.40 (0.28 –2.52) 0.85 (−0.36 – 2.07) 0.86 (−0.34 – 2.07)
p = 0.01, r2 = 0.03 p = 0.16, r2 = 0.15 p = 0.16, r2 = 0.14
Restless Leg Syndrome −0.21 (−1.21 – 0.79) −0.87 (−1.89 – 0.15) −0.90 (−1.91 – 0.11)
p = 0.68, r2 = 0.001 p = 0.09, r2 = 0.15 p = 0.08, r2 = 0.14
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pain, compared to subjects with localized pain [7, 38]. No
previous study has looked at the association between
TMD pain duration and increasing number of pain sites.
However, previous studies exist looking at persistent
TMD pain, which could be comparable to long duration
of TMD pain. For example, a longitudinal study revealed
that the number of bodily pain sites were positively as-
sociated with having a persistent TMD pain (pain after
5 years), compared to TMD patients in remission (no
pain after 5 years), with odds of 1.81 [11]. Other studiesTable 4 Results of multiple linear regression models between como
group (n = 121)
Dependent variables Independent variables Crude M
Coefficie
p value,




Chronic Fatigue Syndrome 5.38 (1.9
p < 0.01,
Irritable Bowel Syndrome 3.08 (0.0
p = 0.05,
Interstitial Cystitis 2.04 (−2
p = 0.32,
Restless Leg Syndrome −0.23 (−
p = 0.90,showed that baseline widespread pain was the most predict-
ive factor for persistent TMD pain (OR= 1.78 - 1.99) [6, 39].
The relationship between the presence of comorbidi-
ties and TMD pain duration and intensity appear to be
related to central sensitization [40, 41]. TMD patients
with comorbidities have evidence of central sensitization
and allodynia [42, 43], which may explain the increased
TMD pain duration and intensity. As well, chronic TMD
is associated with neural abnormalities in the trigeminal
and limbic systems, which may be related to spreading
of pain to other body parts [44].rbidities and TMD pain duration in participants in the m-TMD
odel Complex model Simple model
nt (95 % CI) Coefficient (95 % CI) Coefficient (95 % CI)
r2 value p value, r2 value p value, r2 value
5 – 2.66) 1.53 (0.33 – 2.73) 1.44 (0.25 – 2.62),
r2 = 0.05 p < 0.05, r2 = 0.07 p < 0.05, r2 = 0.11
.72 – 3.94) 0.34 (−2.60 – 3.28) −0.01 (−2.89 –2.87)
r2 = 0.01 p = 0.82, r2 = 0.18 p = 0.99, r2 = 0.17
1 – 8.84), 5.98 (2.16 – 9.79), 5.54 (1.78 – 9.30),
r = 0.07 p < 0.01, r2 = 0.18 p < 0.01, r2 = 0.17
6 – 6.09) 3.14 (0.04 – 6.25) 3.14 (0.04 – 6.23)
r2 = 0.03 p = 0.05, r2 = 0.18 p = 0.05, r2 = 0.17
.01 – 6.09) −0.88 (5.17 – 3.42) −0.71 (−4.98 – 3.56)
r2 = 0.01 p = 0.69, r2 = 0.18 p = 0.74, r2 = 0.17
4.03 – 3.56) −1.74 (−5.54 – 2.07) −1.69 (−5.47 – 2.09)
r2 = 0.001 p = 0.37, r2 = 0.18 p = 0.38, r2 = 0.17
Table 5 Results of multiple linear regression models between comorbidities and TMD pain intensity in participants in the m-TMD
group (n = 121)
Dependent variables Independent variables Crude Model Complex model Simple model
Coefficient (95 % CI) Coefficient (95 % CI) Coefficient (95 % CI)
p value, r2 value p value, r2 value p value, r2 value
TMD intensity (0–10) Number of comorbidity 0.63 (0.31 – 0.95), 0.60 (0.25 – 0.94), 0.62 (0.27 – 0.95),
p < 0.01, r2 = 0.11 p < 0.01, r2 = 0.13 p < 0.01, r2 = 0.13
Migraine 1.45 (0.64 – 2.25), 1.08 (0.21 – 1.95), 1.08 (0.23 – 1.93),
p < 0.01, r2 = 0.10 p < 0.05, r2 = 0.18 p < 0.05, r2 = 0.18
Chronic Fatigue Syndrome 1.82 (0.81 – 2.85), 1.42 (0.29 – 2.54), 1.42 (0.30 – 2.53),
p < 0.01, r2 = 0.10 p < 0.05, r2 = 0.18 p < 0.05, r2 = 0.18
Irritable Bowel Syndrome 0.36 (−0.56 – 1.27) −0.05 (−0.97 – 0.87) −0.05 (−0.97 – 0.87)
p = 0.44, r2 = 0.01 p = 0.91, r2 = 0.18 p = 0.91, r2 = 0.18
Interstitial Cystitis 1.36 (0.18 – 2.55) 0.71 (−0.56 – 1.98) 0.70 (−0.56 – 1.97)
p = 0.03, r2 = 0.04 p = 0.27, r2 = 0.18 p = 0.27, r2 = 0.18
Restless Leg Syndrome 0.61 (−0.51 – 1.74) −0.12 (−1.25 – 0.99) −0.13 (−1.24 – 0.99)
p = 0.28, r2 = 0.01 p = 0.82, r2 = 0.18 p = 0.82, r2 = 0.18
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associated with an increased TMD intensity. Migraine is
prevalent among TMD patients, with a prevalence of mi-
graine 22–58 % [45–47] and it is associated with increased
physical and psychosocial disability [14–17]. The associ-
ation between migraine and increased TMD pain intensity
has been observed in a prior study, where the relative risk
of having moderate/severe TMD compared to mild TMD
with migraine comorbidity was 7.8 [47]. Furthermore, an
association between frequency of headaches and TMD
pain duration and intensity has been observed [48]. We
also show that CFS is associated with TMD pain intensityTable 6 Results of multiple linear regression models between como
group (n = 59)
Dependent variables Independent variables Crude M
Coefficie
p value,




Chronic Fatigue Syndrome 14.90 (5.
p < 0.05,
Irritable Bowel Syndrome 2.80 (−2
p = 0.30,
Interstitial Cystitis 10.20 (2.
p = 0.01,
Restless Leg Syndrome 5.52 (−0
p = 0.07,and duration. The association between CFS and TMD
pain duration was exceptionally high, suggesting a more
profound central sensitization [49]. CFS is a condition that
can overlap with TMD (20 %) [50]. However, fibromyalgia
(FM), a condition that overlaps with both TMD and CFS
was not controlled for in our study [49]. TMD patients
with FM experience more intense and prolonged pain
than TMD patients without FM [49]. Therefore, it is pos-
sible that the influence of CFS on TMD pain intensity and
duration was partially or fully mediated by the presence of
FM. The other conditions, IBS, IC and RLS were not associ-
ated with either TMD pain intensity or duration. However,rbidities and TMD pain duration in participants in the j-TMD
odel Complex model Simple model
nt (95 % CI) Coefficient (95 % CI) Coefficient (95 % CI)
r2 value p value, r2 value p value, r2 value
0 – 4.73), 2.54 (0.31 – 4.77), 2.38 (0.33 – 4.44),
r2 = 0.12 p < 0.05, r2 = 0.21 p < 0.05, r2 = 0.20
.59 – 7.46) 0.05 (−5.83 – 5.93) 0.39 (−5.40 – 6.17)
r2 = 0.02 p = 0.99, r2 = 0.26 p = 0.89, r2 = 0.25
23 – 24.55) 8.20 (−4.20 – 20.60), 9.89 (−1.71 – 21.48),
r2 = 0.14 p = 0.19, r2 = 0.26 p = 0.09, r2 = 0.25
.53 – 8.14) 0.69 (−5.36 – 6.74) 0.69 (4.96 – 6.34)
r2 = 0.02 p = 0.82, r2 = 0.26 p = 0.81, r2 = 0.25
43 – 17.98) 5.58 (−4.99 –16.14) 3.64 (−6.05 – 13.33)
r2 = 0.11 p = 0.29, r2 = 0.26 p = 0.45, r2 = 0.25
.40 – 11.45) 2.86 (−3.99 – 9.70) 2.30 (−4.20 – 8.81)
r2 = 0.06 p = 0.41, r2 = 0.26 p = 0.48, r2 = 0.25
Table 7 Results of multiple linear regression models between comorbidities and TMD pain intensity in participants in the j-TMD
group (n = 59)
Dependent variables Independent variables Crude Model Complex model Simple model
Coefficient (95 % CI) Coefficient (95 % CI) Coefficient (95 % CI)
p value, r2 value p value, r2 value p value, r2 value
TMD intensity (0–10) Number of comorbidity 0.24 (−0.44 – 0.92) 0.20 (−0.57 – 0.97) 0.12 (−0.59 – 0.84)
p = 0.49, r2 = 0.01 p = 0.60, r2 = 0.09 p = 0.73, r2 = 0.09
Migraine 0.99 (−0.64 – 2.61) 0.34 (−1.62 – 2.32) 0.34 (−1.67 – 2.29)
p = 0.23, r2 = 0.03 p = 0.73, r2 = 0.19 p = 0.73, r2 = 0.19
Chronic Fatigue Syndrome 0.84 (−2.54 – 4.22) 0.08 (−3.94 – 4.09) −0.08 (−4.00 – 3.82)
p = 0.62, r2 = 0.004 p = 0.97, r2 = 0.19 p = 0.97, r2 = 0.19
Irritable Bowel Syndrome 1.17 (−0.55 – 2.90) 0.75 (−1.29 – 2.79) 0.59 (−1.31 – 2.50)
p = 0.18, r2 = 0.03 p = 0.47, r2 = 0.19 p = 0.53, r2 = 0.19
Interstitial Cystitis 1.16 (−1.50 – 3.82) 1.65 (1.66 – 4.97) 1.73 (−1.53 – 5.01)
p = 0.39, r2 = 0.01 p = 0.32, r2 = 0.19 p = 0.29, r2 = 0.19
Restless Leg Syndrome −1.85 (−3.77 – 0.08) −2.13 (4.42 – 0.14) −2.26 (−4.46 – −0.07)
p = 0.06, r2 = 0.06 p = 0.07, r2 = 0.19 p = 0.04, r2 = 0.19
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size; an ad-hoc sample size calculation revealed that the
sample size would need to be 333 to statistically ob-
serve an association if the effect size was small (f2 =
0.05), based on the numbers of predictors that were
used in the current study.
This study also shows a difference between the m-
TMD and j-TMD groups, where the j-TMD group did
not display strong associations between most outcome
and exposure variables. This may support the notion
that j-TMD disease does not involve central sensitization
[51–53]. However, an association between migraine and
both m-TMD and j-TMD has been previously observed
[54]. Since the sample size of j-TMD group was smaller
than the m-TMD group (n = 59 vs. 121, respectively),
the study may have been underpowered. Specifically, the
regression results between CFS and TMD pain duration
suggest that an association may exist but was not ad-
equately detected.
This study has some limitations. Firstly, being a cross-
sectional study, it cannot provide information regarding
the direction of association between comorbidities and
pain characteristics in TMD patients. Secondly, the sub-
jects were people seeking treatment at a hospital center
for TMD. They may not represent the average profile of
a TMD patient, which has been shown to have acute,
self-limiting pain [55]. Therefore, our study results could
be more generalizable for people with chronic TMD
seeking treatment. Thirdly, the study focused on the im-
pact of specific comorbidities on TMD pain characteristics
without taking into account the intensity or duration of
these disorders. Other possible limitations include rela-
tively small sample size that could result in missing certainassociations in the final analysis, measurement errors, par-
ticularly for pain duration. Finally, a measurement bias
may exist since emotional distress and psychological status
may not have been adequately assessed and controlled for
all subjects [56]. To assess psychological variables, patients
were asked about a history of depression and anxiety,
responding with a simple yes/no answer. A more accurate
assessment could be done using a validated surveys like the
Hospital Anxiety and Depression Scale [57].
Conclusions
This study shows that in people with chronic TMD, in-
creasing number of comorbid conditions was positively
associated with TMD pain duration and intensity. Also,
the presence of some conditions, such as migraine and
CFS, are associated with increased TMD intensity and
duration. These findings could be clinically relevant,
suggesting that in order to improve TMD symptoms
other existing comorbidities need to be assessed and
addressed, probably in interdisciplinary clinics hosting
multiple health professions [55].
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